These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16781677)

  • 1. Crystal structure of rat carnitine palmitoyltransferase II (CPT-II).
    Hsiao YS; Jogl G; Esser V; Tong L
    Biochem Biophys Res Commun; 2006 Aug; 346(3):974-80. PubMed ID: 16781677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural model of the catalytic core of carnitine palmitoyltransferase I and carnitine octanoyltransferase (COT): mutation of CPT I histidine 473 and alanine 381 and COT alanine 238 impairs the catalytic activity.
    Morillas M; Gómez-Puertas P; Roca R; Serra D; Asins G; Valencia A; Hegardt FG
    J Biol Chem; 2001 Nov; 276(48):45001-8. PubMed ID: 11553629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural model of carnitine palmitoyltransferase I based on the carnitine acetyltransferase crystal.
    Morillas M; López-Viñas E; Valencia A; Serra D; Gómez-Puertas P; Hegardt FG; Asins G
    Biochem J; 2004 May; 379(Pt 3):777-84. PubMed ID: 14711372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The crystal structure of carnitine palmitoyltransferase 2 and implications for diabetes treatment.
    Rufer AC; Thoma R; Benz J; Stihle M; Gsell B; De Roo E; Banner DW; Mueller F; Chomienne O; Hennig M
    Structure; 2006 Apr; 14(4):713-23. PubMed ID: 16615913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A monotopic membrane protein goes solo.
    Mattevi A
    Structure; 2006 Apr; 14(4):628-9. PubMed ID: 16615901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective modulation of carnitine long-chain acyltransferase activities. Kinetics, inhibitors, and active sites of COT and CPT-II.
    Ramsay RR; Gandour RD
    Adv Exp Med Biol; 1999; 466():103-9. PubMed ID: 10709633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional studies of yeast-expressed human heart muscle carnitine palmitoyltransferase I.
    Zhu H; Shi J; de Vries Y; Arvidson DN; Cregg JM; Woldegiorgis G
    Arch Biochem Biophys; 1997 Nov; 347(1):53-61. PubMed ID: 9344464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenesis of specific amino acids converts carnitine acetyltransferase into carnitine palmitoyltransferase.
    Cordente AG; López-Viñas E; Vázquez MI; Gómez-Puertas P; Asins G; Serra D; Hegardt FG
    Biochemistry; 2006 May; 45(19):6133-41. PubMed ID: 16681386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carnitine palmitoyltransferase 2: analysis of membrane association and complex structure with a substrate analog.
    Rufer AC; Lomize A; Benz J; Chomienne O; Thoma R; Hennig M
    FEBS Lett; 2007 Jul; 581(17):3247-52. PubMed ID: 17585909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catalytically important domains of rat carnitine palmitoyltransferase II as determined by site-directed mutagenesis and chemical modification. Evidence for a critical histidine residue.
    Brown NF; Anderson RC; Caplan SL; Foster DW; McGarry JD
    J Biol Chem; 1994 Jul; 269(29):19157-62. PubMed ID: 8034673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rat liver mitochondrial contact sites and carnitine palmitoyltransferase-I.
    Hoppel C; Kerner J; Turkaly P; Tandler B
    Arch Biochem Biophys; 2001 Aug; 392(2):321-5. PubMed ID: 11488608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carnitine and carnitine palmitoyltransferase in fatty acid oxidation and ketosis.
    Hoppel CL
    Fed Proc; 1982 Oct; 41(12):2853-7. PubMed ID: 7128831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active sites residues of beef liver carnitine octanoyltransferase (COT) and carnitine palmitoyltransferase (CPT-II).
    Nic a'Bháird N; Yankovskaya V; Ramsay RR
    Biochem J; 1998 Mar; 330 ( Pt 2)(Pt 2):1029-36. PubMed ID: 9480926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning and expression of the liver and muscle isoforms of ovine carnitine palmitoyltransferase 1: residues within the N-terminus of the muscle isoform influence the kinetic properties of the enzyme.
    Price NT; Jackson VN; van der Leij FR; Cameron JM; Travers MT; Bartelds B; Huijkman NC; Zammit VA
    Biochem J; 2003 Jun; 372(Pt 3):871-9. PubMed ID: 12662154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of carnitine acetyltransferase and implications for the catalytic mechanism and fatty acid transport.
    Jogl G; Tong L
    Cell; 2003 Jan; 112(1):113-22. PubMed ID: 12526798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation in the heart of mitochondrial carnitine palmitoyltransferase-I muscle and liver isoforms.
    Park EA; Cook GA
    Mol Cell Biochem; 1998 Mar; 180(1-2):27-32. PubMed ID: 9546627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscle Carnitine Palmitoyltransferase II Deficiency: A Review of Enzymatic Controversy and Clinical Features.
    Lehmann D; Motlagh L; Robaa D; Zierz S
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28054946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional and structural basis of carnitine palmitoyltransferase 1A deficiency.
    Gobin S; Thuillier L; Jogl G; Faye A; Tong L; Chi M; Bonnefont JP; Girard J; Prip-Buus C
    J Biol Chem; 2003 Dec; 278(50):50428-34. PubMed ID: 14517221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural insight into function and regulation of carnitine palmitoyltransferase.
    Rufer AC; Thoma R; Hennig M
    Cell Mol Life Sci; 2009 Aug; 66(15):2489-501. PubMed ID: 19430727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of carnitine palmitoyltransferases in patients with a carnitine palmitoyltransferase deficiency: implications for diagnosis and therapy.
    Schaefer J; Jackson S; Taroni F; Swift P; Turnbull DM
    J Neurol Neurosurg Psychiatry; 1997 Feb; 62(2):169-76. PubMed ID: 9048718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.